A planned GSK expansion moves the London-based pharmaceutical company beyond Montgomery County and Philadelphia into Lancaster. GlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, announced a landmark investment of up to $800 million to expand its Pennsylvania manufacturing operations, reports John George for the Philadelphia Business Journal.